Akari Therapeutics, plc

Q3 2020 13F Holders

Symbol
AKTX
CUSIP
00972G108
Type
Equity
Class
SPONSORED ADR
Num filings
16
Total reported value, excl. options
$2.54 M
Manager Report Date Value ($000) Shares Option Type